The Genelabs Technologies brand, founded in 1983 (United States), from 1722 sister brands and 17477 competing brands. Genelabs Technologies is owned by GSK PLC, listed on the stock exchange of Francfort Its International Securities Identification Number (ISIN) is GB00BN7SWP63. The sector of Genelabs Technologies is Drug Manufacturers.

Genelabs Technologies is a brand of GSK PLC (GS71) Share price

Date created : 1983 Business sector Drug Manufacturers

Share price and profitability of the share GSK PLC (Genelabs Technologies)

Buy GSK PLC share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested EUR 18.23

Portfolio valuation
GSK PLC (Genelabs Technologies) over 5 years* EUR 14.72

Stock market history GSK PLC (Genelabs Technologies)

*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances

Other brands
GSK PLC

Twinrix
Twinrix
Trizivir
Trizivir
Triumeq
Triumeq
Retrovir
Retrovir
Pediarix
Pediarix
Mepron
Mepron
See more brands of GSK PLC

Rival brands
Genelabs Technologies

POINT BIOPHARMA
POINT BIOPHARMA
Icosavax
Icosavax
OGX
OGX
MAUI MOISTURE
MAUI MOISTURE
POLYSPORIN
POLYSPORIN
LACTAID
LACTAID
OTHER RIVAL BRANDS

Top Popularity Web

See the full ranking
Desirable brands > Pricing Power > 5 major sectors
Desirable brands > Pricing Power > 5 major sectors

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more
MORE NEWS